These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31447267)
21. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices. Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124 [TBL] [Abstract][Full Text] [Related]
22. Perceptions of Medicare Part D enrollees about pharmacists and their role as providers of medication therapy management. Law AV; Okamoto MP; Brock K J Am Pharm Assoc (2003); 2008; 48(5):648-53. PubMed ID: 18826904 [TBL] [Abstract][Full Text] [Related]
23. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593 [TBL] [Abstract][Full Text] [Related]
24. Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing Strategies for Improving Medication Use Among Beneficiaries Enrolled in Medicare Part D. Brandt NJ; Cooke CE Clin Geriatr Med; 2017 May; 33(2):153-164. PubMed ID: 28364988 [TBL] [Abstract][Full Text] [Related]
26. Discrepancies identified with the use of prescription claims and diagnostic billing data following a comprehensive medication review. Roane TE; Patel V; Hardin H; Knoblich M J Manag Care Pharm; 2014 Feb; 20(2):165-73. PubMed ID: 24456318 [TBL] [Abstract][Full Text] [Related]
27. Should eligibility for medication therapy management be based on drug adherence? Stuart B; Loh E; Miller L; Roberto P J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767 [TBL] [Abstract][Full Text] [Related]
28. A new ballgame: comprehensive medication review. McSpadden C Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results. O'Shea TE; Zarowitz BJ; Erwin WG J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922 [TBL] [Abstract][Full Text] [Related]
30. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries. Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497 [TBL] [Abstract][Full Text] [Related]
31. Strategies for community-based medication management services in value-based health plans. Smith MA; Spiggle S; McConnell B Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962 [TBL] [Abstract][Full Text] [Related]
32. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007. Winston S; Lin YS J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047 [TBL] [Abstract][Full Text] [Related]
33. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Moczygemba LR; Barner JC; Lawson KA; Brown CM; Gabrillo ER; Godley P; Johnsrud M Am J Geriatr Pharmacother; 2011 Oct; 9(5):328-38. PubMed ID: 21865093 [TBL] [Abstract][Full Text] [Related]
34. Utility of a brief screening tool for medication-related problems. Snyder ME; Pater KS; Frail CK; Hudmon KS; Doebbeling BN; Smith RB Res Social Adm Pharm; 2015; 11(2):253-64. PubMed ID: 25443640 [TBL] [Abstract][Full Text] [Related]
35. Potential cost savings of medication therapy management in safety-net clinics. Truong HA; Groves CN; Congdon HB; Dang DT; Botchway R; Thomas J J Am Pharm Assoc (2003); 2015; 55(3):269-72. PubMed ID: 25816340 [TBL] [Abstract][Full Text] [Related]
36. Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations. Collins JC; Hu J; McMillan SS; O'Reilly CL; El-Den S; Kelly F; Spinks J; Riley T; Wheeler AJ J Pharm Policy Pract; 2023 Nov; 16(1):133. PubMed ID: 37919809 [TBL] [Abstract][Full Text] [Related]
37. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program. Allen A; Hung A J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629 [TBL] [Abstract][Full Text] [Related]
38. Survey of medication therapy management programs under Medicare part D. Touchette DR; Burns AL; Bough MA; Blackburn JC J Am Pharm Assoc (2003); 2006; 46(6):683-91. PubMed ID: 17176683 [TBL] [Abstract][Full Text] [Related]
39. The impact of pharmacist practice of medication therapy management in ambulatory care: an experience from a comprehensive Chinese hospital. Meng Q; Sun L; Ma Y; Wei Y; Ma X; Yang L; Xie Z; Li F; Wang Z; Tao X; Zhen X; Jin R; Gu H BMC Health Serv Res; 2023 Feb; 23(1):176. PubMed ID: 36810022 [TBL] [Abstract][Full Text] [Related]
40. Pharmacist medication therapy management in home health care: Investigation of a sustainable practice model. Corsi K; Lemay V; Orr KK; Cohen L J Am Pharm Assoc (2003); 2018; 58(4S):S64-S68. PubMed ID: 29887258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]